What is RedLeaf Biologics worth?
$14.8Mlast known valuation
RedLeaf Biologics last raised $750K in its Seed Round (Sep 2019).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for RedLeaf Biologics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2019 | Seed Round | $750K | ▮ | ▮ |
| Jun 2015 | Seed Round | $250K | ▮ | ▮ |
How RedLeaf Biologics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For RedLeaf Biologics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is RedLeaf Biologics worth?
- RedLeaf Biologics's last known valuation is $14.8M.
- How much has RedLeaf Biologics raised?
- RedLeaf Biologics has raised $1.3M in total funding across 2 recorded rounds.
- When did RedLeaf Biologics last raise?
- RedLeaf Biologics last raised in Sep 2019 (Seed Round), raising $750K.